These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3111729)

  • 21. Diabetic cataracts in animal models: prevention and reversibility with aldose reductase inhibitors.
    Kador PF; Akagi Y; Kinoshita JH
    Diabet Med; 1985 May; 2(3):194-6. PubMed ID: 2952419
    [No Abstract]   [Full Text] [Related]  

  • 22. N-[5-(trifluoromethyl)-6-methoxy-1-naphthalenyl]thioxomethyl]- N-methylglycine (Tolrestat), a potent, orally active aldose reductase inhibitor.
    Sestanj K; Bellini F; Fung S; Abraham N; Treasurywala A; Humber L; Simard-Duquesne N; Dvornik D
    J Med Chem; 1984 Mar; 27(3):255-6. PubMed ID: 6422042
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of rat lens aldose reductase by bendazac-L-lysine salt.
    Iuliano G; Menzione M; Apponi-Battini G; Costagliola C
    Enzyme; 1989; 42(4):235-7. PubMed ID: 2517113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in the susceptibility of various aldose reductases to inhibition. II.
    Kador PF; Kinoshita JH; Tung WH; Chylack LT
    Invest Ophthalmol Vis Sci; 1980 Aug; 19(8):980-2. PubMed ID: 6773903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-activity correlation of flavonoids for inhibition of bovine lens aldose reductase.
    Iinuma M; Tanaka T; Mizuno M; Katsuzaki T; Ogawa H
    Chem Pharm Bull (Tokyo); 1989 Jul; 37(7):1813-5. PubMed ID: 2509087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and synthesis of 2-(arylamino)-4(3H)-quinazolinones as novel inhibitors of rat lens aldose reductase.
    DeRuiter J; Brubaker AN; Millen J; Riley TN
    J Med Chem; 1986 May; 29(5):627-9. PubMed ID: 3084783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of polyol pathway activity in diabetic and galactosemic rats by the aldose reductase inhibitor CP-45,634.
    Peterson MJ; Sarges R; Aldinger CE; MacDonald DP
    Adv Exp Med Biol; 1979; 119():347-56. PubMed ID: 115231
    [No Abstract]   [Full Text] [Related]  

  • 28. [2,2',4,4'-tetrahydroxybenzophenone as a new aldose reductase inhibitor (author's transl)].
    Ono H; Hayano S
    Nippon Ganka Gakkai Zasshi; 1982; 86(4):353-7. PubMed ID: 6810663
    [No Abstract]   [Full Text] [Related]  

  • 29. Inhibition of lens and cataract aldose reductase by protein-bound anti-rheumatic drugs: salicylate, indomethacin, oxyphenbutazone, sulindac.
    Sharma YR; Cotlier E
    Exp Eye Res; 1982 Jul; 35(1):21-7. PubMed ID: 6807700
    [No Abstract]   [Full Text] [Related]  

  • 30. Structure-activity studies of aldose reductase inhibitors containing the 4-oxo-4h-chromen ring system.
    Kador PF; Sharpless NE
    Biophys Chem; 1978 Mar; 8(1):81-5. PubMed ID: 417745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N- and 2-substituted N-(phenylsulfonyl)glycines as inhibitors of rat lens aldose reductase.
    DeRuiter J; Borne RF; Mayfield CA
    J Med Chem; 1989 Jan; 32(1):145-51. PubMed ID: 2491890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidiabetic and aldose reductase activities of biflavanones of Garcinia kola.
    Iwu MM; Igboko OA; Okunji CO; Tempesta MS
    J Pharm Pharmacol; 1990 Apr; 42(4):290-2. PubMed ID: 1974302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on WF-3681, a novel aldose reductase inhibitor. I. Taxonomy, fermentation, isolation and characterization.
    Nishikawa M; Tsurumi Y; Namiki T; Yoshida K; Okuhara M
    J Antibiot (Tokyo); 1987 Oct; 40(10):1394-9. PubMed ID: 3119547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Aldose-reductase inhibitors and cataract formation (author's transl)].
    Keller G; Leuenberger PM
    Klin Monbl Augenheilkd; 1980 Apr; 176(4):514-5. PubMed ID: 6775130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inhibition of rat lens aldose reductase by flavonoids-matteucinol and baicalein].
    Li SZ; Mao WS; Du XY; Liang SW; Hu BR; Ma YQ
    Yan Ke Xue Bao; 1987 Jun; 3(2):93-4, 137. PubMed ID: 3149594
    [No Abstract]   [Full Text] [Related]  

  • 36. Synthesis and aldose reductase-inhibitory activities of structural analogues of WF-3681, a novel aldose reductase inhibitor.
    Namiki T; Baba Y; Suzuki Y; Nishikawa M; Sawada K; Itoh Y; Oku T; Kitaura Y; Hashimoto M
    Chem Pharm Bull (Tokyo); 1988 Apr; 36(4):1404-14. PubMed ID: 3138031
    [No Abstract]   [Full Text] [Related]  

  • 37. Medicinal chemistry of aldose reductase inhibitors.
    Larson ER; Lipinski CA; Sarges R
    Med Res Rev; 1988; 8(2):159-86. PubMed ID: 3132580
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of human lens aldose reductase by flavonoids, sulindac and indomethacin.
    Chaudhry PS; Cabrera J; Juliani HR; Varma SD
    Biochem Pharmacol; 1983 Jul; 32(13):1995-8. PubMed ID: 6409111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of M79175, an aldose reductase inhibitor, on experimental sugar cataracts].
    Ono H; Nozawa Y; Hayano S
    Nippon Ganka Gakkai Zasshi; 1982; 86(9):1343-50. PubMed ID: 6818854
    [No Abstract]   [Full Text] [Related]  

  • 40. Computer-assisted design and synthesis of novel aldose reductase inhibitors.
    Butera J; Bagli J; Doubleday W; Humber L; Treasurywala A; Loughney D; Sestanj K; Millen J; Sredy J
    J Med Chem; 1989 Apr; 32(4):757-65. PubMed ID: 2539477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.